Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19

Interim Guidance

27 September 2022
 | COVID-19: Vaccines
Interim recommendations for use of the Novavax NVX-CoV2373 vaccine against COVID-19
Download (461.8 kB)

Overview

These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below. 

For translations of this document in other languages, click here.

Related documents:

Archived versions:

 

 

WHO Team
Strategic Advisory Group of Experts on Immunization
Number of pages
13
Reference numbers
WHO Reference Number: WHO/2019-nCoV/vaccines/SAGE_recommendation/Novavax_NVX-CoV2373/2021.1
Copyright